New imaging technique to improve lung cancer treatment
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
This study is testing a new imaging technique that helps doctors see how well your lungs are working, which could make radiation therapy for lung cancer safer and more effective by protecting healthy lung tissue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11211200 on NIH RePORTER |
What this research studies
This research focuses on developing a novel lung function imaging technique called 4DCT-ventilation, which aims to enhance the management of lung cancer patients undergoing radiation therapy. By creating detailed lung ventilation maps, this approach seeks to minimize harmful side effects associated with radiation treatment. The project involves an academic-industrial partnership to translate this innovative imaging modality into clinical practice, with the goal of improving patient outcomes and quality of life. Early-phase trials have shown promising results, indicating that this method could lead to better treatment plans that avoid damaging healthy lung tissue.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients who are receiving radiation therapy.
Not a fit: Patients who are not undergoing radiation therapy for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the side effects of radiation therapy for lung cancer patients, leading to improved quality of life.
How similar studies have performed: There is emerging evidence from early-phase trials that supports the effectiveness of similar imaging techniques in improving treatment outcomes for lung cancer patients.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vinogradskiy, Yevgeniy — Thomas Jefferson University
- Study coordinator: Vinogradskiy, Yevgeniy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.